Neurology India
Open access journal indexed with Index Medicus
  Users online: 1207  
 Home | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article


    Article Cited by others

Botulinum toxin treatment of hemifacial spasm and blepharospasm : objective response evaluation.

Thussu A, Barman C R, Prabhakar S

Year : 1999| Volume: 47| Issue : 3 | Page no: 206-9

   This article has been cited by
1 Blepharospasm and hemifacial spasm: Long-term treatment with botulinum toxin [Blefarospasmo y espasmo hemifacial: Tratamiento a largo plazo con toxina botulínica]
Gil Polo, C. and Rodríguez Sanz, M.F. and Berrocal Izquierdo, N. and Castrillo Sanz, A. and Gutiérrez Ríos, R. and Zamora García, M.I. and Mendoza Rodríguez, A. and Duarte García-Luis, J.
Neurologia. 2013; 28(3): 131-136
[Pubmed]  [Google Scholar]
2 Effects of botulinum toxin type a on quality of life assessed with the WHOQOL-BREF in hemifacial spasm and blepharospasm
Gürsoy, A.E. and Ugurad, I. and Babacan-Yildiz, G. and Kolukisa, M. and Çelebi, A.
Neurology Psychiatry and Brain Research. 2013; 19(1): 12-18
[Pubmed]  [Google Scholar]
3 Efficacy of botulinum toxin injections in the treatment of various types of facial region disorders [Yüz bölgesi hastaliklarinin çeşitli tiplerinde botulinum toksini enjeksiyonlarinin etkinliǧi]
Joban, A. and Matur, Z. and Hanaǧasi, H.A. and Parman, Y.
Turk Noroloji Dergisi. 2012; 18(4): 133-161
[Pubmed]  [Google Scholar]
4 Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia [Influência da toxina botulínica tipo A na função lacrimal de pacientes com distonias faciais]
de Oliveira, F.C. and de Oliveira, G.C. and Cariello, A.J. and Felberg, S. and Osaki, M.H.
Arquivos Brasileiros de Oftalmologia. 2010; 73(5): 405-408
[Pubmed]  [Google Scholar]
5 Botulinum toxin type A in the treatment of hemifacial spasm: An 11-year experience [Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência]
Barbosa, E.R. and Takada, L.T. and Gonçalves, L.R. and Costa, R.M.P.N. and Silveira-Moriyama, L. and Chien, H.F.
Arquivos de Neuro-Psiquiatria. 2010; 68(4): 502-505
[Pubmed]  [Google Scholar]
6 The effects of botulinum toxin a on ephaptic transmission in idiopathic hemifacial spasm
Kurt, T. and Seçil, Y. and Gürgör, N. and Tokuçoǧlu, F. and Beckmann, Y. and Ertekin, C.
International Journal of Neuroscience. 2009; 119(11): 2044-2055
[Pubmed]  [Google Scholar]
7 Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs
Bentivoglio, A.R. and Fasano, A. and Ialongo, T. and Soleti, F. and Lo Fermo, S. and Albanese, A.
Neurotoxicity Research. 2009; 15(3): 224-231
[Pubmed]  [Google Scholar]
8 Relationship between various clinical outcome assessments in patients with blepharospasm
Jankovic, J. and Kenney, C. and Grafe, S. and Goertelmeyer, R. and Comes, G.
Movement Disorders. 2009; 24(3): 407-413
[Pubmed]  [Google Scholar]
9 Efficacy and safety of purified botulinum toxin type A (Dysport®) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial
Truong, D. and Comella, C. and Fernandez, H.H. and Ondo, W.G.
Parkinsonism and Related Disorders. 2008; 14(5): 407-414
[Pubmed]  [Google Scholar]
10 Essential blepharospasm and hemifacial spasm: Characteristic of the patient, botulinum toxin A treatment and literature review [Blefarospasmo essencial e espasmo hemifacial: Características dos pacientes, tratamento com toxina botulínica A e revisão da literatura]
Schellini, S.A. and Matai, O. and Igami, T.Z. and Padovani, C.R. and Padovani, C.P.
Arquivos Brasileiros de Oftalmologia. 2006; 69(1): 23-26
[Pubmed]  [Google Scholar]


Online since 20th March '04
Published by Wolters Kluwer - Medknow